-
公开(公告)号：US20170348312A1
公开(公告)日：2017-12-07
申请号：US15538348
申请日：2015-12-21
申请人： Ho Man CHAN , Xiang-Ju Justin GU , Ying HUANG , Ling LI , Yuan MI , Wei QI , Martin SENDZIK , Yongfeng SUN , Long WANG , Zhengtian YU , Hailong ZHANG , Ji Yue (Jeff) ZHANG , Man ZHANG , Qiong ZHANG , Kehao ZHAO
发明人： Ho Man CHAN , Xiang-Ju Justin GU , Ying HUANG , Ling LI , Yuan MI , Wei QI , Martin SENDZIK , Yongfeng SUN , Long WANG , Zhengtian YU , Hailong ZHANG , Ji Yue (Jeff) ZHANG , Man ZHANG , Qiong ZHANG , Kehao ZHAO
IPC分类号： A61K31/519 , A61K31/551 , A61K31/541 , C07D487/04 , A61K31/5377
CPC分类号： A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K45/06 , C07D487/04
摘要： A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.
-
公开(公告)号：US20160176882A1
公开(公告)日：2016-06-23
申请号：US14977273
申请日：2015-12-21
申请人： Ho Man CHAN , Xiang-Ju Justin GU , Ying HUANG , Ling LI , Yuan MI , Wei QI , Martin SENDZIK , Yongfeng SUN , Long WANG , Zhengtian YU , Hailong ZHANG , Ji Yue (Jeff) ZHANG , Man ZHANG , Qiong ZHANG , Kehao ZHAO
发明人： Ho Man CHAN , Xiang-Ju Justin GU , Ying HUANG , Ling LI , Yuan MI , Wei QI , Martin SENDZIK , Yongfeng SUN , Long WANG , Zhengtian YU , Hailong ZHANG , Ji Yue (Jeff) ZHANG , Man ZHANG , Qiong ZHANG , Kehao ZHAO
IPC分类号： C07D487/04 , A61K31/551 , A61K31/5377 , A61K31/541 , A61K31/519 , A61K45/06
CPC分类号： A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K45/06 , C07D487/04
摘要： A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.
摘要翻译： 提供式（I）化合物或其药学上可接受的盐，其已被证明可用于治疗PRC2介导的疾病或病症：其中R1，R2，R3，R4，R5和n如所定义 这里。
-
公开(公告)号：US09580437B2
公开(公告)日：2017-02-28
申请号：US14977273
申请日：2015-12-21
申请人： Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao
发明人： Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao
IPC分类号： C07D487/04 , A61K31/519 , A61K31/541 , A61K31/551 , A61K45/06 , A61K31/5377
CPC分类号： A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K45/06 , C07D487/04
摘要： A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.
摘要翻译： 提供式（I）化合物或其药学上可接受的盐，其已被证明可用于治疗PRC2介导的疾病或病症：其中R1，R2，R3，R4，R5和n如所定义 这里。
-
公开(公告)号：USD577428S1
公开(公告)日：2008-09-23
申请号：US29302517
申请日：2008-01-18
申请人： Yongfeng Sun
设计人： Yongfeng Sun
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
